Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

IART May 5, 2026

Integra LifeSciences Q1 2026 Earnings Call - CEO Returns, Guidance Raised, and Commercial Reset

Integra LifeSciences delivered a strong first quarter with revenue of $392 million and adjusted EPS of $0.54, beating the high end of guidance. The company maintained its full-year revenue outlook at ...

  • CEO Stuart Essig returns to lead the company, stepping back into the role previously held by Mojdeh Poul, with a focus on commercial execution and culture.
  • Full-year adjusted EPS guidance raised to $2.40-$2.50 from prior expectations, driven by tariff benefits and margin improvement.
  • Q1 revenue of $392 million beat guidance, with organic growth of 1.3% and strong performance in Tissue Reconstruction.
  • +7 more takeaways
ULS May 5, 2026

UL Solutions Q1 2026 Earnings Call - Margin Expansion and Strategic M&A Drive Outperformance

UL Solutions delivered a standout first quarter in 2026, posting consolidated revenue growth of 7.5% and adjusted EBITDA margin expansion of 320 basis points to 26.0%. The results were driven by disci...

  • Consolidated revenue grew 7.5% year-over-year to $758 million, with organic revenue growth of 5.7%, outpacing expectations.
  • Adjusted EBITDA surged 22.4% to $197 million, driving a 320 basis point expansion in adjusted EBITDA margin to 26.0%.
  • Management raised full-year 2026 adjusted EBITDA margin guidance to approximately 27.0%, up from the previous range, citing strong Q1 performance and restructuring savings.
  • +7 more takeaways
ADTN May 5, 2026

ADTRAN Holdings Q1 2026 Earnings Call - Margin Expansion and Data Center Pivot Amid Supply Chain Headwinds

ADTRAN Holdings reported a solid first quarter in 2026, with revenue climbing 15.5% year-over-year to $286.1 million and non-GAAP operating margins expanding 300 basis points to 6.9%. The results were...

  • Revenue reached $286.1 million, up 15.5% year-over-year, driven by broad-based strength across optical, access, and subscriber segments.
  • Non-GAAP operating margin expanded 300 basis points to 6.9%, marking the highest level since 2020 despite supply chain headwinds.
  • Optical Networking Solutions revenue surged 24% year-over-year to $97.3 million, fueled by European vendor displacement and hyperscaler demand.
  • +7 more takeaways
HQ May 5, 2026

Horizon Quantum Q1 2026 Earnings Call - Public Debut with $96.6M Cash, Hardware Testbeds, and Beryllium Language Push

Horizon Quantum has officially entered the public markets following its business combination with dMY Squared Technology Group, listing on Nasdaq and raising $101 million in net financing proceeds. Th...

  • Horizon Quantum completed its business combination with dMY Squared Technology Group on March 19, 2026, becoming a public company listed on Nasdaq.
  • The company raised $101 million in net financing proceeds, ending the quarter with $96.6 million in cash on the balance sheet.
  • Total operating expenses increased to $6.5 million from $4.7 million year-over-year, primarily due to a doubling of the science and engineering headcount.
  • +7 more takeaways
APTV May 5, 2026

Aptiv Q1 2026 Earnings Call - Separation of Versigent Drives Sharper Focus on Software and Non-Automotive Growth

Aptiv delivered Q1 2026 results marked by the successful spin-off of its Electrical Distribution Systems (EDS) business into Versigent, a move designed to sharpen its focus on advanced software and ha...

  • Aptiv successfully completed the separation of its Electrical Distribution Systems (EDS) business into a new independent public company, Versigent, allowing the remaining entity to focus on advanced software and optimized hardware solutions.
  • Q1 2026 revenue reached $5.1 billion, up 1% year-over-year on an adjusted basis, while adjusted EPS hit a record $1.71, driven by lower interest expense and a reduced share count.
  • The company secured $7 billion in new business awards during the quarter, including $900 million from non-automotive customers, underscoring a strategic pivot beyond traditional automotive markets.
  • +7 more takeaways
DOCN May 5, 2026

DigitalOcean Q1 2026 Earnings Call - AI-Native Cloud Launch Drives 221% AI ARR Growth

DigitalOcean delivered a record Q1 2026, accelerating revenue growth to 22% year-over-year and raising its full-year 2026 revenue growth guidance to 25-27%. The company’s strategic pivot to an AI-Nati...

  • Q1 2026 revenue reached $258 million, up 22% year-over-year, beating the top end of guidance and accelerating from Q4 2025’s 18% growth rate.
  • AI customer ARR surged 221% year-over-year to $170 million, with over 80% of that revenue attributed to inference services and core cloud pull-through rather than bare metal.
  • Million-dollar customer ARR grew 179% year-over-year to $183 million, reflecting strong expansion among top-tier cloud and AI-native clients.
  • +7 more takeaways
SEAT May 5, 2026

Vivid Seats Q1 2026 Earnings Call - App Growth and Private Label Turnaround Drive Sequential Momentum

Vivid Seats reported a strong first quarter 2026, landing at the high end of guidance with sequential growth in gross ticket value (GOV), adjusted EBITDA, and cash. The company’s strategic pivot towar...

  • Q1 2026 GOV reached $612 million, up 5.5% sequentially from Q4 2025, defying typical seasonal weakness in the first quarter.
  • Consolidated revenue came in at $126 million, essentially flat quarter-over-quarter, with a take rate of 15.9% due to mix shift toward lower-margin private label revenue.
  • Adjusted EBITDA surged to $9.5 million from $1 million in Q4 2025, driven by disciplined cost reductions and operating leverage as revenue stabilized.
  • +11 more takeaways
CCJ May 5, 2026

Cameco Corporation Q1 2026 Earnings Call - Nuclear Execution Replaces Aspiration as U.S. Reactor Pipeline Accelerates

Cameco’s Q1 2026 results reflect disciplined execution amid a structural shift in nuclear policy, with management emphasizing that durable demand growth requires sustained supply discipline and long-t...

  • Management reaffirmed full-year 2026 guidance, citing Q1 performance as consistent with expectations and driven by timing and pricing rather than fundamental shifts.
  • U.S. Department of Commerce and Department of Energy are advancing parallel pathways for AP1000 deployment, targeting up to 20 reactors with a combined $80 billion commitment.
  • Westinghouse reported improved adjusted EBITDA despite a net loss, reflecting normal project variability and amortization of acquisition-related intangibles.
  • +7 more takeaways
ALKS May 5, 2026

Alkermes Q1 2026 Earnings Call - Avadel Acquisition Drives Revenue Beat and Expands Orexin Pipeline

Alkermes delivered a strong first quarter of 2026, with proprietary net sales jumping 38% year-over-year to $338.1 million, fueled by solid demand across its psychiatry and addiction franchises and th...

  • Alkermes completed the acquisition of Avadel Pharmaceuticals in mid-February, integrating LUMRYZ into its portfolio and establishing an immediate commercial presence in sleep medicine ahead of its lead orexin-2 receptor agonist candidate, alixorexton.
  • First-quarter proprietary net sales surged 38% year-over-year to $338.1 million, beating prior expectations, driven by strong performance in psychiatry (ARISTADA, LYBALVI) and addiction (VIVITROL), plus six weeks of LUMRYZ revenue.
  • LUMRYZ generated $72 million in net revenue for the quarter, with approximately $39.5 million recorded in the first six weeks post-acquisition; the company exited Q1 with about 3,600 patients on therapy and expects $315-$335 million in full-year LUMRYZ sales.
  • +7 more takeaways
INTT May 5, 2026

inTEST Corporation Q1 2026 Earnings Call - Raised FY26 Guidance on Diverse Demand and Operating Leverage

inTEST delivered a strong Q1 2026, with revenue of $33.9 million and adjusted EBITDA of $3.2 million, both beating guidance. The company raised its full-year 2026 revenue guidance to $130-$135 million...

  • Q1 2026 revenue reached $33.9 million, up 27% year-over-year, beating the upper end of guidance.
  • Adjusted EBITDA came in at $3.2 million with a 9.3% margin, exceeding expectations and driven by favorable product mix and operating leverage.
  • Full-year 2026 revenue guidance was raised to $130-$135 million, reflecting diversified demand and improved market conditions.
  • +7 more takeaways